GGrantIndex
← Leaderboards

Naren L Banik

Medical University Of South Carolina

$13,192,318
Attributed
$13,397,880
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,397,880 · 8
VA$0 · 4

By mechanism

R01$12,986,755 · 7
R21$411,125 · 1
I01$0 · 3
IK6$0 · 1

Top collaborators

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Others in their field

Top investigators on “Calpain

Research focus

CalpainSpinal CordNeuronsCellsInflammatoryInflammationMyelinIn VitroCell DeathRattusAttenuatedCalpain InhibitorProductionCytokineEventNerve DegenerationNeurogliaAcuteMediatingApoptosisAxonChronicCalciumTissues

Grant awards (70)

Research Career Scientist for Naren Banik, PhD$0
IK6 · FY2025 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2025 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2024 · VA · contact PI
Research Career Scientist for Naren Banik, PhD$0
IK6 · FY2024 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2023 · VA · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2023 · VA · contact PI
Research Career Scientist for Naren Banik, PhD$0
IK6 · FY2023 · VA · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2022 · VA · contact PI
Research Career Scientist for Naren Banik, PhD$0
IK6 · FY2022 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2022 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2021 · VA · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2021 · VA · contact PI
Calpain cleavage of α-synuclein and T-cell reactivity in Parkinson’s disease$411,125
R21 · FY2020 · NS
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2020 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2020 · VA · contact PI
Attenuation of Inflammatory Response in Progressive Neurodegeneration in Parkinson's Disease$0
I01 · FY2019 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2019 · VA · contact PI
Regulation of inflammatory T Cells and Neuroprotection by Calpain Inhibitor in MS$0
I01 · FY2017 · VA · contact PI
Regulation of inflammatory T Cells and Neuroprotection by Calpain Inhibitor in MS$0
I01 · FY2016 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2016 · VA · contact PI
Regulation of inflammatory T Cells and Neuroprotection by Calpain Inhibitor in MS$0
I01 · FY2015 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2015 · VA · contact PI
Regulation of inflammatory T Cells and Neuroprotection by Calpain Inhibitor in MS$0
I01 · FY2014 · VA · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2014 · VA · contact PI
Inflammation and Degeneration of Optic Nerve in EAE$303,570
R01 · FY2013 · NS · contact PI
Extra-nigral Neurodegeneration in Experimental Parkinson's Disease$303,374
R01 · FY2013 · NS · contact PI
Hormonal Intervention Protects Axon-myelin to Promote Functional Recovery in SCI$0
I01 · FY2013 · VA · contact PI
Inflammation and Degeneration of Optic Nerve in EAE$314,580
R01 · FY2012 · NS · contact PI
Extra-nigral Neurodegeneration in Experimental Parkinson's Disease$314,377
R01 · FY2012 · NS · contact PI
Inflammation and Degeneration of Optic Nerve in EAE$314,580
R01 · FY2011 · NS · contact PI
Extra-nigral Neurodegeneration in Experimental Parkinson's Disease$314,377
R01 · FY2011 · NS · contact PI
Role of Proteinase in Spinal Cord Injury$312,988
R01 · FY2011 · NS · contact PI
Attenuation of Axonal Damage and Neuronal Death in EAE$350,872
R01 · FY2010 · NS · contact PI
Inflammation and Degeneration of Optic Nerve in EAE$317,790
R01 · FY2010 · NS · contact PI
Extra-nigral Neurodegeneration in Experimental Parkinson's Disease$317,585
R01 · FY2010 · NS · contact PI
Role of Proteinase in Spinal Cord Injury$316,182
R01 · FY2010 · NS · contact PI
Attenuation of Axonal Damage and Neuronal Death in EAE$354,415
R01 · FY2009 · NS · contact PI
Inflammation and Degeneration of Optic Nerve in EAE$332,875
R01 · FY2009 · NS · contact PI
Extra-nigral Neurodegeneration in Experimental Parkinson's Disease$331,184
R01 · FY2009 · NS · contact PI
Role of Proteinase in Spinal Cord Injury$319,375
R01 · FY2009 · NS · contact PI
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$318,974
R01 · FY2009 · NS · contact PI
Attenuation of Axonal Damage and Neuronal Death in EAE$354,415
R01 · FY2008 · NS · contact PI
Role of Proteinase in Spinal Cord Injury$319,375
R01 · FY2008 · NS · contact PI
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$318,974
R01 · FY2008 · NS · contact PI
Attenuation of Axonal Damage and Neuronal Death in EAE$354,415
R01 · FY2007 · NS · contact PI
Role of Proteinase in Spinal Cord Injury$319,375
R01 · FY2007 · NS · contact PI
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$318,974
R01 · FY2007 · NS · contact PI
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$324,360
R01 · FY2006 · NS · contact PI
ESTROGEN EFFICACY IN SPINAL CORD INJURY$230,784
R01 · FY2006 · NS · contact PI
Attenuation of Axonal Damage and Neuronal Death in EAE$176,290
R01 · FY2006 · NS · contact PI
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$321,750
R01 · FY2005 · NS
ROLE OF PROTEINASE IN SPINAL CORD INJURY$318,175
R01 · FY2005 · NS
ESTROGEN EFFICACY IN SPINAL CORD INJURY$236,338
R01 · FY2005 · NS
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$321,750
R01 · FY2004 · NS
ROLE OF PROTEINASE IN SPINAL CORD INJURY$318,175
R01 · FY2004 · NS
ESTROGEN EFFICACY IN SPINAL CORD INJURY$270,100
R01 · FY2004 · NS
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$321,750
R01 · FY2003 · NS
ROLE OF PROTEINASE IN SPINAL CORD INJURY$318,175
R01 · FY2003 · NS
ESTROGEN EFFICACY IN SPINAL CORD INJURY$258,600
R01 · FY2003 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$210,721
R01 · FY2003 · NS
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$346,750
R01 · FY2002 · NS
ROLE OF PROTEINASE IN SPINAL CORD INJURY$307,425
R01 · FY2002 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$227,732
R01 · FY2002 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$5,001
R01 · FY2002 · NS
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE$346,750
R01 · FY2001 · NS
PROTEINASE AND SPINAL CORD INJURY$268,389
R01 · FY2001 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$217,014
R01 · FY2001 · NS
PROTEINASE AND SPINAL CORD INJURY$260,549
R01 · FY2000 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$218,885
R01 · FY2000 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE$38,666
R01 · FY2000 · NS